Tatsinkou Liliane Laure Toukam, Fossi Bertrand Tatsinkou, Sotoing Germain Taiwe, Mambou Hart Mann Alain Youbi, Ivo Peter Enyong Ayuk, Achidi Eric Akum
Department of Microbiology and Parasitology, Faculty of Science, University of Buea, PO Box 63, Buea, Cameroon.
Department of Microbiology and Parasitology, Faculty of Science, University of Buea, PO Box 63, Buea, Cameroon.
Life Sci. 2023 Oct 15;331:122056. doi: 10.1016/j.lfs.2023.122056. Epub 2023 Aug 29.
Malaria is a deadly parasitic disease caused a by protozoan parasite of the genus plasmodium. The challenges facing by chemotherapy and vector control couple with the lack of vaccine against malaria necessitate an urgent need for the development of alternative treatment regimens to combat this disease. One possible antimalarial treatment regimen is the use of probiotic bacteria as dietary supplements. Traditionally fermented milk is a rich source of probiotic bacteria that up to date, very few studies have been carried out on their immunoprotective effects against early malaria infection in mice. This study sought to assess the prophylactic activities of a probiotic bacterium Latilactobacillus sakei on malaria and inflammation in Plasmodium berghei infected mice. The probiotic bacterium was isolated from the Fulani's traditionally fermented milk and identified using the sequencing of the 16S r RNA gene. The repository activity of L. sakei on malaria was assessed using the method described by Peters with slight modification. Eighty-four BALB/c mice were randomly divided into two sets of seven groups of six mice each. One set received orally different doses of L. sakei Chloroquine and Sulfadoxine/Pyrimethamine for seven days before infection while the other set received for fourteen days before infection with 0.1 mL of 10Plasmodium berghei. Parasitaemia density, haematological parameters and inflammatory cytokines profile were evaluated. Data were presented as Mean ± SEM and analysed using SPSS version 20.0. The results of this study revealed that L. sakei significantly (p < 0.05) reduced in dose dependent manner parasite load, body weight loss and reduction of body temperature in all the treated mice when compare to untreated mice. Leukocytopenia, thrombocytosis and inflammation were also found to be significantly (p < 0.05) prevented in treated mice as compared to untreated mice. This study suggested that L sakei possesses immunomodulation and protective effects on early malaria infection in Plasmodium berghei mice.
疟疾是一种由疟原虫属原生动物寄生虫引起的致命寄生虫病。化疗和病媒控制面临的挑战,再加上缺乏疟疾疫苗,迫切需要开发替代治疗方案来对抗这种疾病。一种可能的抗疟疾治疗方案是使用益生菌作为膳食补充剂。传统发酵乳是益生菌的丰富来源,但迄今为止,针对其对小鼠早期疟疾感染的免疫保护作用的研究很少。本研究旨在评估益生菌清酒乳杆菌对感染伯氏疟原虫的小鼠疟疾和炎症的预防作用。该益生菌是从富拉尼人传统发酵乳中分离出来的,并通过16S rRNA基因测序进行鉴定。清酒乳杆菌对疟疾的抑制活性采用彼得斯描述的方法并稍作修改进行评估。84只BALB/c小鼠随机分为两组,每组七组,每组六只。一组在感染前7天口服不同剂量的清酒乳杆菌氯喹和磺胺多辛/乙胺嘧啶,另一组在感染前14天口服0.1mL含10个伯氏疟原虫的溶液。评估了寄生虫血症密度、血液学参数和炎症细胞因子谱。数据以平均值±标准误表示,并使用SPSS 20.0版进行分析。本研究结果显示,与未治疗的小鼠相比,清酒乳杆菌在所有治疗小鼠中均以剂量依赖性方式显著(p<0.05)降低了寄生虫载量、体重减轻和体温降低。与未治疗的小鼠相比,治疗小鼠的白细胞减少、血小板增多和炎症也被显著(p<0.05)预防。本研究表明,清酒乳杆菌对伯氏疟原虫感染小鼠的早期疟疾感染具有免疫调节和保护作用。